{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:38:33Z","timestamp":1792474713166,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.psychres.2022.114577","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T21:47:43Z","timestamp":1650923263000},"page":"114577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies"],"prefix":"10.1016","volume":"313","author":[{"given":"Hartej","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnian","family":"Puramat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barjot","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9Ann A.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle S.","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo B.","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Daniel","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psychres.2022.114577_bib0001","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2022.114577_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116980","article-title":"Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention","volume":"218","author":"Barrett","year":"2020","journal-title":"Neuroimage"},{"issue":"23","key":"10.1016\/j.psychres.2022.114577_bib0003","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.0700436104","article-title":"Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex","volume":"104","author":"B\u00e9\u00efque","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.psychres.2022.114577_bib0004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114577_bib0005","series-title":"LSD psychotherapy: An exploration of Psychedelic and Psycholytic Therapy","author":"Caldwell","year":"1968"},{"issue":"2","key":"10.1016\/j.psychres.2022.114577_bib0006","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"In Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2022.114577_bib0007","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.bp.111.103309","article-title":"Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin","volume":"200","author":"Carhart-Harris","year":"2012","journal-title":"In Br. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2022.114577_bib0008","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2022.114577_bib0010","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The Therapeutic Potential of Psychedelic Drugs: past, Present, and Future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2022.114577_bib0011","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.psychres.2022.114577_bib0012","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/13894501113149990154","article-title":"Inflammation, serotonin and major depression","volume":"14","author":"Catena-Dell'Osso","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"8","key":"10.1016\/j.psychres.2022.114577_bib0013","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/sj.npp.1301593","article-title":"Functional coupling of the amygdala in depressed patients treated with antidepressant medication","volume":"33","author":"Chen","year":"2008","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2022.114577_bib0014","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","author":"Davis","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2022.114577_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1071\/AH16115","article-title":"A review of the economic impact of mental illness","volume":"43","author":"Doran","year":"2019","journal-title":"Australian Health Review: A Publication of the Australian Hospital Association"},{"issue":"9","key":"10.1016\/j.psychres.2022.114577_bib0016","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","article-title":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews","volume":"11","author":"Dos Santos","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2022.114577_bib0017","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","volume":"237","author":"Family","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2022.114577_bib0018","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugpo.2019.05.019","article-title":"Psychedelic-assisted therapies: the past, and the need to move forward responsibly","volume":"70","author":"Gardner","year":"2019","journal-title":"Int. J. Drug Policy"},{"issue":"12","key":"10.1016\/j.psychres.2022.114577_bib0019","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/14737175.2020.1826931","article-title":"The emerging role of psilocybin and MDMA in the treatment of mental illness","volume":"20","author":"Gill","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.psychres.2022.114577_bib0020","series-title":"The Road to Eleusis: Unveiling the Secret of the Mysteries","author":"Gordon Wasson","year":"2008"},{"issue":"12","key":"10.1016\/j.psychres.2022.114577_bib0021","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2022.114577_bib0022","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.euroneuro.2018.03.016","article-title":"Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination","volume":"28","author":"Grimm","year":"2018","journal-title":"European Neuropsychopharmacology: The J.European College of Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2022.114577_bib0023","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/npp.2008.81","article-title":"Altered negative BOLD responses in the default-mode network during emotion processing in depressed subjects","volume":"34","author":"Grimm","year":"2009","journal-title":"Neuropsychopharmacol.: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2022.114577_bib0024","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10100","key":"10.1016\/j.psychres.2022.114577_bib0025","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Hay","year":"2017","journal-title":"Lancet North Am. Ed."},{"issue":"3","key":"10.1016\/j.psychres.2022.114577_bib0026","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02159243","article-title":"Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim","volume":"14","author":"Hofmann","year":"1958","journal-title":"Experientia"},{"issue":"1","key":"10.1016\/j.psychres.2022.114577_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66784-2","article-title":"Validating a functional near-infrared spectroscopy diagnostic paradigm for major depressive disorder","volume":"10","author":"Husain","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.psychres.2022.114577_bib0028","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"25","key":"10.1016\/j.psychres.2022.114577_bib0029","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations","volume":"33","author":"Kometer","year":"2013","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.psychres.2022.114577_bib0030","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114577_bib0031","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nicl.2015.08.009","article-title":"The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity","volume":"11","author":"Kraehenmann","year":"2016","journal-title":"Neuroimage Clin."},{"issue":"8","key":"10.1016\/j.psychres.2022.114577_bib0032","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/hbm.22833","article-title":"Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin","volume":"36","author":"Lebedev","year":"2015","journal-title":"In Hum. Brain Mapping"},{"issue":"1","key":"10.1016\/j.psychres.2022.114577_bib0033","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","article-title":"Molecular mechanisms of psilocybin and implications for the treatment of depression","volume":"36","author":"Ling","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2022.114577_bib0034","doi-asserted-by":"crossref","unstructured":"Lord, L.-.D., Expert, P., Atasoy, S., Roseman, L., Rapuano, K., Lambiotte, R., Nutt, D.J., Deco, G., Carhart-Harris, R.L., Kringelbach, M.L., & Cabral, J. (2018). Altered trajectories in the dynamical repertoire of functional network states under psilocybin. In Cold Spring Harbor Laboratory(p. 376491). https:\/\/doi.org\/10.1101\/376491.","DOI":"10.1101\/376491"},{"issue":"11","key":"10.1016\/j.psychres.2022.114577_bib0035","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.psychres.2022.114577_bib0036","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"Int. J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2022.114577_bib0037","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int. J. Surgery"},{"issue":"11","key":"10.1016\/j.psychres.2022.114577_bib0038","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114577_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.psychres.2022.114577_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","article-title":"Psilocybin induces time-dependent changes in global functional connectivity","volume":"88","author":"Preller","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114577_bib0041","article-title":"SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli","volume":"11","author":"Preuss","year":"2020","journal-title":"Front. Psychiatry \/Front. Res. Foundation"},{"key":"10.1016\/j.psychres.2022.114577_bib0042","unstructured":"RoB 2: A revised Cochrane risk-of-bias tool for randomized trials. (n.d.). Retrieved August 28, 2019, from https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials."},{"key":"10.1016\/j.psychres.2022.114577_bib0043","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.psychres.2022.114577_bib0044","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2022.114577_bib0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/foc.6.1.foc128","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"6","author":"Rush","year":"2008","journal-title":"In FOCUS"},{"key":"10.1016\/j.psychres.2022.114577_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2017.00419","article-title":"Functional magnetic resonance imaging and functional near-infrared spectroscopy: insights from combined recording studies","volume":"11","author":"Scarapicchia","year":"2017","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.psychres.2022.114577_bib0047","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"Smigielski","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.psychres.2022.114577_bib0048","series-title":"Storming Heaven: LSD and the American Dream","author":"Stevens","year":"1987"},{"issue":"12","key":"10.1016\/j.psychres.2022.114577_bib0049","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.euroneuro.2016.09.640","article-title":"Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration","volume":"26","author":"Vai","year":"2016","journal-title":"European Neuropsychopharmacol.: The J. European College of Neuropsychopharmacol."},{"issue":"22","key":"10.1016\/j.psychres.2022.114577_bib0050","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/S0024-3205(03)00141-3","article-title":"5-HT2A and 5-HT2C receptors and their atypical regulation properties","volume":"72","author":"Van Oekelen","year":"2003","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.psychres.2022.114577_bib0051","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.psychres.2022.114577_bib0052","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF02244617","article-title":"5HT-2 mediation of acute behavioral effects of hallucinogens in rats","volume":"100","author":"Wing","year":"1990","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.psychres.2022.114577_bib0053","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:55:39Z","timestamp":1759038939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178122001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":52,"alternative-id":["S0165178122001871"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114577","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114577"}}